Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GVP
2276
DELISTED
GSE Systems, Inc.
GVP
| $1.87M | ﹤0.01% |
55,070
+1,950
| +4% | +$63.6K |
|
2277
Foster
FSTR
$404M
| $1.86M | ﹤0.01% |
149,200
+3,700
| +3% | +$51.1K |
|
|
VRTV
2278
DELISTED
VERITIV CORPORATION
VRTV
| $1.86M | ﹤0.01% |
35,900
+21,800
| +155% | +$1.2M |
|
|
SMED
2279
DELISTED
Sharps Compliance Corp
SMED
| $1.85M | ﹤0.01% |
389,300
-13,400
| -3% | -$61.6K |
|
|
BNCN
2280
DELISTED
BNC Bancorp
BNCN
| $1.85M | ﹤0.01% |
52,792
-58,759
| -53% | -$2.04M |
|
|
SPAN
2281
DELISTED
Span-America Medical Systems I
SPAN
| $1.85M | ﹤0.01% |
85,100
+7,500
| +10% | +$155K |
|
2282
Limoneira
LMNR
$250M
| $1.84M | ﹤0.01% |
88,200
-48,200
| -35% | -$895K |
|
|
VYNT
2283
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
| $1.84M | ﹤0.01% |
2,997
+928
| +45% | +$330K |
|
|
ALO
2284
DELISTED
Alio Gold Inc
ALO
| $1.84M | ﹤0.01% |
489,752
+63,102
| +15% | +$235K |
|
2285
BioCryst Pharmaceuticals
BCRX
$2.51B
| $1.84M | ﹤0.01% |
219,203
+169,300
| +339% | +$1.18M |
|
|
FSBK
2286
DELISTED
First South Bancorp Inc/VA
FSBK
| $1.84M | ﹤0.01% |
151,600
+12,500
| +9% | +$150K |
|
|
COVS
2287
DELISTED
Covisint Corporation
COVS
| $1.83M | ﹤0.01% |
891,400
-13,900
| -2% | -$27.7K |
|
2288
Addus HomeCare
ADUS
$2.2B
| $1.82M | ﹤0.01% |
57,000
+44,700
| +363% | +$1.51M |
|
2289
USA Compression Partners
USAC
$3.78B
| $1.82M | ﹤0.01% |
107,998
-67,311
| -38% | -$1.2M |
|
|
PRFT
2290
DELISTED
Perficient Inc
PRFT
| $1.82M | ﹤0.01% |
+105,093
| New | +$1.87M |
|
|
PTXP
2291
DELISTED
PennTex Midstream Partners, LP Common Units Reresenting Limited Partnership Interests
PTXP
| $1.82M | ﹤0.01% |
105,583
+63,422
| +150% | +$1.01M |
|
2292
AmeriServ Financial
ASRV
$85M
| $1.82M | ﹤0.01% |
484,700
+85,499
| +21% | +$325K |
|
|
MPSX
2293
DELISTED
Multi Packaging Solutions Intl.
MPSX
| $1.82M | ﹤0.01% |
+101,300
| New | +$1.73M |
|
2294
Lincoln Educational Services
LINC
$955M
| $1.82M | ﹤0.01% |
646,681
+78,981
| +14% | +$170K |
|
2295
Mine Safety
MSA
$7.32B
| $1.81M | ﹤0.01% |
+25,674
| New | +$1.79M |
|
|
GEN
2296
DELISTED
Genesis Healthcare, Inc.
GEN
| $1.81M | ﹤0.01% |
687,000
+369,400
| +116% | +$1.33M |
|
|
QUMU
2297
DELISTED
Qumu Corp.
QUMU
| $1.81M | ﹤0.01% |
642,100
+6,741
| +1% | +$15.9K |
|
2298
DMC Global
BOOM
$153M
| $1.81M | ﹤0.01% |
146,000
+7,432
| +5% | +$112K |
|
|
TESO
2299
DELISTED
Tesco Corp
TESO
| $1.81M | ﹤0.01% |
224,900
-46,000
| -17% | -$390K |
|
|
HEP
2300
DELISTED
Holly Energy Partners, L.P.
HEP
| $1.81M | ﹤0.01% |
50,627
-24,224
| -32% | -$856K |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.